Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Lidocaine Hydrochloride Monohydrate
Laboratoire AGUETTANT
N01BB02
Lidocaine Hydrochloride Monohydrate
20 milligram(s)/millilitre
Solution for injection/infusion
lidocaine
Not marketed
2020-11-13
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT LIDOKAIN AGUETTANT 20 MG/ML, SOLUTION FOR INJECTION/INFUSION lidocaine hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. Whatis and what it is used for 2. What you need to know before you are given Read the complete document3. How is given 4. Possible side effects 5. How to store 6. Contents of the pack and other information 1. WHAT IS AND WHAT IT IS USED FOR contains the active substance lidocaine hydrochloride which is a local anaesthetic. is used in adults to numb part of the body during small surgical procedures. It stops the nerves from being able to pass pain messages to the brain and so stops you feeling pain. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN YOU MUST NOT BE GIVEN : - if you are allergic to lidocaine hydrochloride, to local anaesthetics of the amide type or any of the other ingredients of this medicine (listed in section 6). - if you have very low blood pressure, or if you have lost too much blood or other body fluids or your heart is unable to pump enough blood for other reasons, you should not get injected into your spine. WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before you are given : - if you are elderly or in a generally debilitated condition. - if you have heart disorders including disorders in the heart's electrical conduction system, heart block , slow heartbeat, and heart failure. - if you have lung or breathing disorder. - if you have any kidney or liver disease. - if you have ep
Health Products Regulatory Authority 25 October 2023 CRN00DQWC Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lidocaine hydrochloride 20 mg/ml, solution for injection/infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution for injection/infusion contains 20 mg of lidocaine hydrochloride (equivalent to 21.33 mg of lidocaine hydrochloride monohydrate). Each 50 ml vial of solution for injection/infusion contains 1000 mg of lidocaine hydrochloride (equivalent to 1066.5 mg of lidocaine hydrochloride monohydrate). Excipients with known effect: This medicinal product contains sodium. Each ml of solution for injection contains 2.0 mg of sodium equivalent to 0.09 mmol of sodium. Each 50-ml vial contains 101 mg of sodium equivalent to 4.4 mmol of sodium. For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection/infusion Clear colourless solution pH: 5.0 to 7.0 Osmolality: 270-320 mOsm/Kg 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lidocaine hydrochloride is indicated in adult patients for use in infiltration anaesthesia, intravenous regional anaesthesia, nerve blocks and epidural anaesthesia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Lidocaine hydrochloride should only be used by, or under the supervision of, doctors with experience of regional anaesthesia and resuscitative skills. Facilities for resuscitation should be available when administering local anaesthetics. Posology The lowest possible dose producing the required effect should be given. The table may serve as a guide for adults having a body weight of about 70 kilograms. The dose should be adjusted according to age, weight and condition of the patient. Route of administration or procedure Recommended doses of Lidocaine hydrochloride Concentration (mg/ml) Volume (ml) Total dose (mg) Infiltration anaesthesia: Large procedures 20mg/ml 5-10 ml 100-200 mg Intravenous regional anaesthesia: Arm 20mg/ml 5-10 ml 100-200 mg Leg 20mg/ml 10 ml 200 mg Nerve blocks 20mg/ml 1-10 ml 20-200 Read the complete document